S&P 500 7,718.60 −0.38%
Nasdaq 26,506.99 −0.29%
S&P/TSX 36,513.80 −0.33%
Apple 319.97 −2.51%
Nvidia 230.36 +0.84%
Microsoft 499.70 −2.04%
Shopify 200.76 −0.10%
Royal Bank 291.48 −0.30%
CAD/USD 0.7233 −0.26%
CLOSED · 16:50 ET
Market ClerkRecap
Sun Sep 6 · markets closed2 signals today321 insider buys this week · $404MCIRO short report next: Sep 15The week ahead
CT
INSIDER · ARQT · Arcutis Biotherapeutics, Inc. · DIRECTOR

Curran Terrie

Every open-market transaction filed under this name, Aug 20 to Aug 27.

Filings
3
0 buys · 3 sells
Bought
open market, at cost
Sold
$984K
includes scheduled sales
Buys since
no current price on file

Filings

SEC FORM 4 · OPEN MARKET
TradedTickerCompanyRoleTypeSharesPriceValueSince
Aug 27ARQTArcutis Biotherapeutics, Inc.DirectorSell27,052$25.03$677K−4.2%
Aug 27ARQTArcutis Biotherapeutics, Inc.DirectorSell11,148$25.03$279K−4.2%
Aug 20ARQTArcutis Biotherapeutics, Inc.DirectorSell1,072$26.04$28K−7.9%

"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.